$Direxion Daily Semiconductor Bull 3x Shares ETF(SOXL.US)$
It's going up in pre
If N rises, it's 116-120; if it falls, the lowest value is 106
L is 44+α if it rises, 39 if it falls
Maybe N could be 122 or more with Rocket 🚀
it's a bit of a lost movementMaybe I'll post again
Tonight, if it rises next Monday, N will have a high of 125, close to L55 (depending on AMD financial results)
The upward movement is supposed to be a 3-way ABC pattern, and there is a possibility that wave A has been completed so far, and it has collapsed in wave BUnless Wave B rises above $108 and breaks the current swing low, C should rebound and retest the 118/115 resistanceThe B wave should not be able to break through the current swing low of $106.50

$Direxion Daily Semiconductor Bull 3x Shares ETF(SOXL.US)$ The VTI I bought in the middle of the year is still in the positive zone. Prices for healthcare etc. have skyrocketed, and there is a risk-off sector rotation. Russell 2000 is also in the high price range since the beginning of the year. Semiconductors have continued to rise since the beginning of the year, so people who have concentrated their investments here may seem to have crashed, but the market itself has not yet undergone significant adjustments. How do they fight back when they are prepared that they are close to the bottom and head out to buy it? I don't want to incite sales separately; it's just about whether you can do super difficult trading by thinking with your own head and referring only to the opinions of others. If you can't do that, then you shouldn't try your hand at leverage. Let's go buy it, or let's get giddy, it's just noise. Other than believing the opinions of mysterious people on bulletin boards even though they can't read them even by professionals. Other than having more information products, etc., the market price is beyond that.

$Metaplanet(3350.JP)$
Stocks that have skyrocketed in recent months are on a downward trend across the board, and while stocks that have skyrocketed within a few days to weeks are crashing across the board.
Based on that, we can almost predict that the metaplanet will once again drop to around 120
The conference is also ahead, and if there is some kind of big surprise, it will rise all at once.
Those who hold it from 2 digits or those who hold it around 100 don't need to be upset about selling it, but those who grab it at a high price, mainly those between 220 and 350, should be prepared to be salted.
There is also a stock merger, so if you don't hold shares in units of 1000 shares, don't forget to sell or buy fractions and keep them ready.
$Yamashin-Filter(6240.JP)$
$CellSeed(7776.JP)$
$SymBio Pharmaceuticals(4582.JP)$

$Metaplanet(3350.JP)$
I went to the vicinity of PTS360 yesterday, so today is really a panic sale ~

$Metaplanet(3350.JP)$
I wonder if the stop was cheap and stuck...

$Metaplanet(3350.JP)$
$MicroStrategy(MSTR.US)$
The total market value is quite different, so it's not comparable, but why doesn't the trading price change as much as the difference in market capitalization?
1-Metapla is in such demand that it is not affected by the BTC rate, and they are buying future potential
Is 2-metapla slightly difficult to buy due to the merger, and is the timing good in terms of exchange from the perspective of overseas players?
Therefore, it is thought that MSTR will go through a split and trading will increase, and I think the trading price of Metapla will decrease due to the merger. I'm oversimplifying it a bit,
It is said that Metapla will be adjusted right away, but aren't major adjustments made before or after annexation?

$Metaplanet(3350.JP)$ Does it still seem like it will rise tomorrow?

$Direxion Daily TSLA Bull 2X Shares(TSLL.US)$
After the financial results, Tesla...

$Direxion Daily TSLA Bull 2X Shares(TSLL.US)$
The settlement date is finally here
Tesla is certain to grow in the future, so I'm steadily increasing during the decline even before financial results
The reason for this is obvious, and after all, because I'm watching Tesla for a long time, I expect there to be a further increase However, as a recent trend, the situation continues to be unstable, with sales being sold even when financial results are good, and rising even if financial results are bad
After all, people who can win in stocks are those who can continue steadily during both falling and rising times can winThis is actually showing up as data isn't it
Selling because it's before the immediate settlement; watching the situation after the immediate settlement; of course, that is also part of the choiceBut when Tesla 🚀 rises, that kind of person probably won't be able to prepareThe opposite is also true, and since it crashed, it may still go downCan't be prepared even during a crash
Maybe it's still going downIt's not the bottom yet
It's gone up so much that I can't buy it...
I missed the shopping place...
It's too expensive nowCan't prepare from
Eventually, that happened, and I missed out on the profit I had obtained if I had held it originally...

Eli Lilly's Obesity Drug Tilzepatide Gets Approval in China
July 22, 2024 9:50 AM GMT+9 (some excerpts)
US pharmaceutical giant Eli Lilly(LY.N)On the 19th, it was announced in a social media post that the obesity treatment drug “tilzepatide” had obtained approval from the Chinese authorities. Danish counterpart Novo Nordisk in key markets(Novob.co)Competition with “Ugobi” becomes even more intense.
Ugobi was approved for sale in China in June.
No response has been obtained from Eli Lilly's spokesperson to a request for comment on the start date and supply volume of tilzepatide in China. This drug is an active ingredient in Eli Lilly's diabetes drug “Manjaro” and weight loss drug “Zepp Bound.” Manjaro is also approved for sale in China.